Replies to post #40916 on SiNtx Technologies Inc (SINT)

[boston745]

One thing particularly interesting since the 2022 RS was the fact that with each announcement of offering the price of the stock would immediately drop 50% or so. That's before such an offering was even closed. Before new shares hit market. Then, because of the exact mechanism I described in my last post the price would be naked shorted another 50% post offering. So if the price was at 50 cents on announcement of a forthcoming offering, offering price then occurred at .25, and then closed out at 12.5ish post offering. There it stood for awhile until the next halving at 4.7 cents.
No negative news was released by the company to justify these drops, it just dropped because it could. However it did this repeatedly showcasing a pattern which shows purpose and collusion. The one major anomaly was when the stock was trading in the 8-9 dollar range and the offering was announced, for some reason at 5.6. Look at the trading history. The stock price hit a high of $12.14 in the 3 trading days before the offering price was announced at 5.6. Then the next day the price halved the previous days low to the low 3's. Funds naked shorted into that offering from as high as 12.14. SEC needs to investigate the trading that has occurred in regards to SINT and the short & distorting thats gone on via social media.

To keep interested buyers away, funds point to how poorly the stock has traded while ensuring it trades that way to support these types of posts, cyclical in nature. Outside of that shorts mostly have to employ deceptive pratices in their posts. These deceptive practices would not be necessary if the company was as bad as they would have people believe.

Take for example this post on ST.

This is a money printing scam has been since ipo Pumps into rs then dilutes to Pennies.

Sintx isnt a scam in the first place. It does have to raise funds via markets to fund R&D no doubt. But this same poster would have people believe that the company has no products that it's selling. That its a shell company. Not that the company has a material that is "destined to become a leader to replace titanium and other entrenched biomaterials". That quote is backed by scientific study completely unrelated to Sintx. Research into the company Implex to see a comparable materials valuation at acquisition. Take note though that Implex acquisition costs were over 200m with 108m being upfront and the rest coming over the next two years as sales milestones were met. This company had 5m in revenue when Zimmer announced its partnership with it. It had 1 product on the market with several pending when it was acquired in 2003.

The rest of the statement is true in the sense that the more the stock price is driven downward the more shares are released per offering. What's missing from this statement however is the fact that its the hfunds buying the offerings that are benefitting from the massive expansion of shares per offering and each reverse split. This is because they short into every RS knowing another offering will come.


========================================

Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.

https://www.mdpi.com/2571-6131/4/2/16/htm

========================================

Silicon Nitride = Next Gen Hip Implant Material

Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies

Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/

========================================

Electromagnetic fields, metal implant corrosion, and dis-ease it causes


https://i.imgur.com/nLg7SXT.jpg

Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/

Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779